share_log

Allogene Therapeutics | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

Allogene Therapeutics | POS EX:招股信息更正说明

SEC announcement ·  2018/10/15 16:01
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息